PortView
iShares U.S. Pharmaceuticals (IHE) ETF Holdings & Analysis
ETFOther
What IHE does
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| JOHNSON & JOHNSON | 22.54% | |
| ELI LILLY | 20.73% | |
| MERCK & CO INC | 5.00% | |
| BRISTOL MYERS SQUIBB | 4.80% | |
| ROYALTY PHARMA PLC CLASS A | 4.48% | |
| PFIZER | 4.38% | |
| VIATRIS | 4.13% | |
| ZOETIS INC CLASS A | 3.82% | |
| JAZZ PHARMACEUTICALS PLC | 3.33% | |
| ELANCO ANIMAL HEALTH | 2.62% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 95.92% |
| Ireland | 3.77% |
| Other | 0.31% |
PortView Portfolio Insights
PortView analyzes how IHE fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze IHE in PortView →Related securities
Related stocks
Frequently asked questions
- What does IHE track?
- IHE is the iShares U.S. Pharmaceuticals ETF, a Other ETF.
- What is the expense ratio of IHE?
- Expense ratio data for IHE is shown on the page when available from our data provider.
- What are the largest holdings in IHE?
- Top holdings include JNJ, LLY, MRK, BMY, RPRX.
- How can PortView analyze IHE overlap with other ETFs?
- PortView computes the holdings overlap between IHE and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.